MX337667B - Combinacion simbiotica para mejorar la microbiota intestinal. - Google Patents

Combinacion simbiotica para mejorar la microbiota intestinal.

Info

Publication number
MX337667B
MX337667B MX2009010252A MX2009010252A MX337667B MX 337667 B MX337667 B MX 337667B MX 2009010252 A MX2009010252 A MX 2009010252A MX 2009010252 A MX2009010252 A MX 2009010252A MX 337667 B MX337667 B MX 337667B
Authority
MX
Mexico
Prior art keywords
3galî2l
galî2l
4glc
galî2
6galî2l
Prior art date
Application number
MX2009010252A
Other languages
English (en)
Other versions
MX2009010252A (es
Inventor
Norbert Sprenger
Marie-Claire Fichot
Karl-Josef Huber-Haag
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2009010252A publication Critical patent/MX2009010252A/es
Publication of MX337667B publication Critical patent/MX337667B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a el uso de una cepa probiótica de Lactobacillus rhamnosus y una mezcla oligsacárida la cual comprende 5-70% en peso de por lo menos un oligosacárido N-acetilado que se selecciona del grupo que comprende GalNAca1,3Galß1,4Glc y Galß1,6GalNAcal,3Galß1,4Glc, 20-90% en peso de por lo menos un oligosacárido neutro que se selecciona del grupo que comprende Galß1,6Gal, Galß1,6Galß1,4Glc Galß1,6Galß1,6G1c, Galß1, 3Galß1, 3Glc, Galß1, 3Galß1, 4Glc, Galß1,6Galß1,6Galß1,4Glc, Galß1,6Galß1,3Galß1,4Glc, Galß1,3Galß1,6Galß14Glc y Galß1,3Galß1,3Galß1,4Glc y 5-50% en peso de por lo menos un oligosacárido sialilado que se selecciona del grupo que comprende NeuAca2,3Galß1,4Glc y NeuAca2,6Galß1,4Glc en la elaboración de un medicamento o una composición nutricional terapéutica para reducir el riesgo de desarrollo subsecuente de alergia en lactantes quienes han nacido por cesárea.
MX2009010252A 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal. MX337667B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053661 WO2008116916A1 (en) 2007-03-28 2008-03-27 Synbiotic to improve gut microbiota

Publications (2)

Publication Number Publication Date
MX2009010252A MX2009010252A (es) 2009-10-13
MX337667B true MX337667B (es) 2016-03-14

Family

ID=38051788

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.

Family Applications After (3)

Application Number Title Priority Date Filing Date
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.

Country Status (15)

Country Link
US (4) US20100119497A1 (es)
EP (6) EP1974743A1 (es)
CN (4) CN101652079A (es)
AU (4) AU2008231763B2 (es)
BR (4) BRPI0809355A2 (es)
CA (4) CA2680093A1 (es)
ES (2) ES2577434T3 (es)
MX (4) MX337667B (es)
MY (1) MY151137A (es)
PL (2) PL2131680T3 (es)
PT (2) PT2131859T (es)
RU (4) RU2009139667A (es)
UA (2) UA97662C2 (es)
WO (4) WO2008116904A1 (es)
ZA (3) ZA200907541B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
MY149913A (en) * 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
AU2007260074B2 (en) * 2006-06-13 2011-12-08 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) * 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
BRPI0922296A2 (pt) * 2008-12-05 2015-08-11 Nestec Sa Composições para o uso em recém-nascidos com baixo peso no nascimento.
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
BR112012002223A2 (pt) * 2009-07-31 2016-06-07 Nestec Sa composição nutricional para lactentes ou animais de estimação com probióticos e nutrientes selecionados
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
BR112013017023A2 (pt) * 2010-12-29 2019-09-24 Nestec Sa fibra e probióticos para a redução dos sintomas instestinais relacionados com o estresse
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス，エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
RU2604502C2 (ru) * 2011-10-18 2016-12-10 Нестек С.А. Композиция, применяемая для стимулирования абсорбции магния и/или удерживания магния
CN108676774B (zh) 2011-12-01 2023-05-09 国立大学法人东京大学 诱导调节性t细胞的增殖或积累的人源细菌
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
DK2994150T3 (da) 2013-05-10 2019-06-11 Heinz Co Brands H J Llc Probiotika og fremgangsmåde til anvendelse
PT3071208T (pt) 2013-11-15 2021-10-26 Nestle Sa Composições para utilização na prevenção ou tratamento de enterocolite necrosante em bebés e crianças pequenas
RU2016123515A (ru) * 2013-11-15 2017-12-20 Нестек С.А. Композиции для применения в целях профилактики или лечения некротизирующего энтероколита у детей грудного и младшего возраста
CN105722514A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
US10758555B2 (en) 2013-11-15 2020-09-01 Societe Des Produits Nestle S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
DK3212208T3 (da) * 2014-10-29 2021-05-17 Biogaia Ab Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet
EP3294308A4 (en) * 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
ES2879985T3 (es) * 2015-08-04 2021-11-23 Nestle Sa Composiciones nutritivas y fórmulas infantiles que comprenden Bifidobacterium animalis ssp. lactis y, opcionalmente, una mezcla de oligosacáridos para inducir una microbiota intestinal cercana a la de bebés alimentados por lactancia materna
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
WO2017129644A1 (en) 2016-01-26 2017-08-03 Nestec S.A. Compositions with specific oligosaccharides to prevent or treat allergies
JP6853821B2 (ja) * 2016-05-31 2021-03-31 森永乳業株式会社 脳機能改善剤
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
RU2748279C2 (ru) * 2016-08-04 2021-05-21 Сосьете Де Продюи Нестле С.А. Питательные композиции и детские смеси, содержащие смесь олигосахаридов и необязательно bifidobacterium lactis для профилактики, лечения или снижения степени тяжести диареи, не связанной с ротавирусом
EP3618843A1 (en) * 2017-05-05 2020-03-11 Société des Produits Nestlé S.A. Treatment of infant colic
US11779614B2 (en) * 2017-08-04 2023-10-10 Societe Des Produits Nestle S.A. Probiotic bacteria preconditioned in a GOS-containing medium and use thereof
US20220010267A1 (en) * 2018-05-30 2022-01-13 Evolve Biosystems, Inc. Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
US20220293275A1 (en) * 2019-06-11 2022-09-15 CJ Bioscience. Inc Method for detecting gut dysbiosis of infant
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
WO2023237679A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2024105265A1 (fr) 2022-11-17 2024-05-23 Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
ES2111625T3 (es) 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
WO2005000748A1 (en) 2003-06-27 2005-01-06 Bio-Circuit Aps A biogas producing facility with anaerobic hydrolysis
MX2007012697A (es) * 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
EP1988786B2 (en) 2006-02-10 2019-10-09 Société des Produits Nestlé S.A. Oligosaccharide mixture
MY149913A (en) * 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
AU2007260074B2 (en) * 2006-06-13 2011-12-08 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains

Also Published As

Publication number Publication date
EP2131859B1 (en) 2016-04-27
BRPI0809356A2 (pt) 2014-09-02
CA2682654A1 (en) 2008-10-02
PL2131859T3 (pl) 2016-12-30
US20100119497A1 (en) 2010-05-13
PT2131680E (pt) 2013-10-28
MX2009009318A (es) 2009-09-10
AU2008231778A1 (en) 2008-10-02
WO2008116904A1 (en) 2008-10-02
CA2678994A1 (en) 2008-03-27
WO2008116907A1 (en) 2008-10-02
PL2131680T3 (pl) 2014-01-31
WO2008116916A1 (en) 2008-10-02
AU2008231702A1 (en) 2008-10-02
RU2521500C2 (ru) 2014-06-27
BRPI0809355A2 (pt) 2014-09-02
BRPI0809622A2 (pt) 2014-09-16
EP2131680A1 (en) 2009-12-16
AU2008231763B2 (en) 2013-10-31
RU2456008C2 (ru) 2012-07-20
ZA200907541B (en) 2011-04-28
ZA200907731B (en) 2011-04-28
US20100119488A1 (en) 2010-05-13
CN101652079A (zh) 2010-02-17
EP2131859A1 (en) 2009-12-16
ES2577434T3 (es) 2016-07-14
UA97662C2 (ru) 2012-03-12
EP2489280A3 (en) 2013-06-26
EP1974743A1 (en) 2008-10-01
ES2434566T3 (es) 2013-12-16
EP2131680B1 (en) 2013-08-14
CA2680093A1 (en) 2008-10-02
UA97663C2 (ru) 2012-03-12
MX2009010252A (es) 2009-10-13
EP2129393A1 (en) 2009-12-09
CA2679081A1 (en) 2008-10-02
CN101652080A (zh) 2010-02-17
EP2489280A2 (en) 2012-08-22
US20100086527A1 (en) 2010-04-08
EP2129242A1 (en) 2009-12-09
RU2009139658A (ru) 2011-05-10
AU2008231702B2 (en) 2014-01-16
MY151137A (en) 2014-04-30
US20100150874A1 (en) 2010-06-17
WO2008116892A1 (en) 2008-10-02
MX2009009931A (es) 2009-09-24
ZA200907538B (en) 2011-04-28
PT2131859T (pt) 2016-07-13
AU2008231763A1 (en) 2008-10-02
CN101646452A (zh) 2010-02-10
RU2009139669A (ru) 2011-05-10
AU2008231775A1 (en) 2008-10-02
RU2009139660A (ru) 2011-05-10
MX2009009442A (es) 2009-09-14
BRPI0809626A2 (pt) 2014-09-23
RU2009139667A (ru) 2011-05-10
CN101646453A (zh) 2010-02-10

Similar Documents

Publication Publication Date Title
MX2009010252A (es) Combinacion simbiotica para mejorar la microbiota intestinal.
RU2008139598A (ru) Синбиотическая смесь
Sánchez-Tapia et al. Diet as regulator of gut microbiota and its role in health and disease
Gibson Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin
RU2010153257A (ru) Пробиотики для улудшения микробиоты пищеварительного тракта
Vernazza et al. Human colonic microbiology and the role of dietary intervention: introduction to prebiotics
EP2643004B1 (en) Oligosaccharide composition for treating skin diseases
Singh et al. Gut microbiome as a novel cardiovascular therapeutic target
RU2014119844A (ru) Композиция для головного мозга и/или познавательного и/или психомоторного развития
RU2010142003A (ru) Синбиотическая смесь
RU2011104195A (ru) Питательная композиция, содержащая смесь олигосахаридов
JP2017533915A5 (es)
NZ601141A (en) Nutritional formulas containing synbiotics
CN113226062A (zh) 包含2’-岩藻糖基乳糖（2’fl）以改善胃肠屏障的营养组合物
RU2014119930A (ru) Композиция, предназначенная для применения в стимулировании здорового костного роста и/или в профилактике, и/или терапии заболеваний кости
UA102830C2 (ru) Профилактика условно-патогенных инфекций у лиц со сниженным иммунитетом
RU2008136876A (ru) Применение bifidobacterium longum для предупреждения и лечения воспаления
MY146109A (en) Oligosaccharide mixture
EP3326634A3 (en) Composition for use in stimulating the intestinal flora in infants delivered by caesarean section
RU2014119903A (ru) Композиция для применения при повышении чувствительности к инсулину и/или снижении инсулинорезистентности
RU2014119904A (ru) Композиция для применения при стимуляции ангиогенеза в кишечнике, всасывания питательных веществ и переносимости энтерального питания, и/или при профилактике, и/или лечении воспалительных заболеваний кишечника, и/или при выздоровлении после повреждения кишечника и хирургического вмешательства
RU2011106319A (ru) Пробиотики для увелечения секреции iga у младенцев, рожденных посредством кесарева сечения
PT2241196E (pt) Suplemento nutricional compreendendo oligossacarídeos e cisteína para o tratamento do vih
RU2016129426A (ru) Питательная композиция для снижения метаболического стресса у младенцев
RU2018139655A (ru) Бифидобактерии для увеличения безжировой массы тела

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration